Report Detail
Global Drug-Eluting Stents Market Insights, Forecast to 2025
- RnM2734280 |
- 21 July, 2020 |
- Global |
- 149 Pages |
- QYResearch |
- Other
Drug-Eluting Stents market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drug-Eluting Stents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Drug-Eluting Stents market is segmented into
Rapamycin
Paclitaxel
Everolimus
Others
Segment by Application, the Drug-Eluting Stents market is segmented into
Angina Pectoris
Myocardial Infarction
Regional and Country-level Analysis
The Drug-Eluting Stents market is analysed and market size information is provided by regions (countries).
The key regions covered in the Drug-Eluting Stents market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Drug-Eluting Stents Market Share Analysis
Drug-Eluting Stents market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Drug-Eluting Stents by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Drug-Eluting Stents business, the date to enter into the Drug-Eluting Stents market, Drug-Eluting Stents product introduction, recent developments, etc.
The major vendors covered:
Boston Scientific
Medtronic, Inc.
Abbott
Lepu Medical
MicroPort Scientific Corporation
Cook Medical
Terumo
Biosensors International
Balton
AlviMedica Medical Technologies
Biotronik
Shandong JW Medical
Sino Medical
Beijing AMSINO
Liaoning Biomedical Materials R&D Center Co.(LBC)
1 Study Coverage
- 1.1 Drug-Eluting Stents Product Introduction
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered: Ranking of Global Top Drug-Eluting Stents Manufacturers by Revenue in 2019
- 1.4 Market by Type
- 1.4.1 Global Drug-Eluting Stents Market Size Growth Rate by Type
- 1.4.2 Rapamycin
- 1.4.3 Paclitaxel
- 1.4.4 Everolimus
- 1.4.5 Others
- 1.5 Market by Application
- 1.5.1 Global Drug-Eluting Stents Market Size Growth Rate by Application
- 1.5.2 Angina Pectoris
- 1.5.3 Myocardial Infarction
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Drug-Eluting Stents Market Size, Estimates and Forecasts
- 2.1.1 Global Drug-Eluting Stents Revenue Estimates and Forecasts 2015-2026
- 2.1.2 Global Drug-Eluting Stents Production Capacity Estimates and Forecasts 2015-2026
- 2.1.3 Global Drug-Eluting Stents Production Estimates and Forecasts 2015-2026
- 2.2 Global Drug-Eluting Stents, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Global Drug-Eluting Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.3.3 Global Drug-Eluting Stents Manufacturers Geographical Distribution
- 2.4 Key Trends for Drug-Eluting Stents Markets & Products
- 2.5 Primary Interviews with Key Drug-Eluting Stents Players (Opinion Leaders)
3 Market Size by Manufacturers
- 3.1 Global Top Drug-Eluting Stents Manufacturers by Production Capacity
- 3.1.1 Global Top Drug-Eluting Stents Manufacturers by Production Capacity (2015-2020)
- 3.1.2 Global Top Drug-Eluting Stents Manufacturers by Production (2015-2020)
- 3.1.3 Global Top Drug-Eluting Stents Manufacturers Market Share by Production
- 3.2 Global Top Drug-Eluting Stents Manufacturers by Revenue
- 3.2.1 Global Top Drug-Eluting Stents Manufacturers by Revenue (2015-2020)
- 3.2.2 Global Top Drug-Eluting Stents Manufacturers Market Share by Revenue (2015-2020)
- 3.2.3 Global Top 10 and Top 5 Companies by Drug-Eluting Stents Revenue in 2019
- 3.3 Global Drug-Eluting Stents Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 Drug-Eluting Stents Production by Regions
- 4.1 Global Drug-Eluting Stents Historic Market Facts & Figures by Regions
- 4.1.1 Global Top Drug-Eluting Stents Regions by Production (2015-2020)
- 4.1.2 Global Top Drug-Eluting Stents Regions by Revenue (2015-2020)
- 4.2 North America
- 4.2.1 North America Drug-Eluting Stents Production (2015-2020)
- 4.2.2 North America Drug-Eluting Stents Revenue (2015-2020)
- 4.2.3 Key Players in North America
- 4.2.4 North America Drug-Eluting Stents Import & Export (2015-2020)
- 4.3 Europe
- 4.3.1 Europe Drug-Eluting Stents Production (2015-2020)
- 4.3.2 Europe Drug-Eluting Stents Revenue (2015-2020)
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Drug-Eluting Stents Import & Export (2015-2020)
- 4.4 China
- 4.4.1 China Drug-Eluting Stents Production (2015-2020)
- 4.4.2 China Drug-Eluting Stents Revenue (2015-2020)
- 4.4.3 Key Players in China
- 4.4.4 China Drug-Eluting Stents Import & Export (2015-2020)
- 4.5 Japan
- 4.5.1 Japan Drug-Eluting Stents Production (2015-2020)
- 4.5.2 Japan Drug-Eluting Stents Revenue (2015-2020)
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Drug-Eluting Stents Import & Export (2015-2020)
5 Drug-Eluting Stents Consumption by Region
- 5.1 Global Top Drug-Eluting Stents Regions by Consumption
- 5.1.1 Global Top Drug-Eluting Stents Regions by Consumption (2015-2020)
- 5.1.2 Global Top Drug-Eluting Stents Regions Market Share by Consumption (2015-2020)
- 5.2 North America
- 5.2.1 North America Drug-Eluting Stents Consumption by Application
- 5.2.2 North America Drug-Eluting Stents Consumption by Countries
- 5.2.3 U.S.
- 5.2.4 Canada
- 5.3 Europe
- 5.3.1 Europe Drug-Eluting Stents Consumption by Application
- 5.3.2 Europe Drug-Eluting Stents Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 U.K.
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Drug-Eluting Stents Consumption by Application
- 5.4.2 Asia Pacific Drug-Eluting Stents Consumption by Regions
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Taiwan
- 5.4.9 Indonesia
- 5.4.10 Thailand
- 5.4.11 Malaysia
- 5.4.12 Philippines
- 5.4.13 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America Drug-Eluting Stents Consumption by Application
- 5.5.2 Central & South America Drug-Eluting Stents Consumption by Country
- 5.5.3 Mexico
- 5.5.3 Brazil
- 5.5.3 Argentina
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Drug-Eluting Stents Consumption by Application
- 5.6.2 Middle East and Africa Drug-Eluting Stents Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 Saudi Arabia
- 5.6.5 U.A.E
6 Market Size by Type (2015-2026)
- 6.1 Global Drug-Eluting Stents Market Size by Type (2015-2020)
- 6.1.1 Global Drug-Eluting Stents Production by Type (2015-2020)
- 6.1.2 Global Drug-Eluting Stents Revenue by Type (2015-2020)
- 6.1.3 Drug-Eluting Stents Price by Type (2015-2020)
- 6.2 Global Drug-Eluting Stents Market Forecast by Type (2021-2026)
- 6.2.1 Global Drug-Eluting Stents Production Forecast by Type (2021-2026)
- 6.2.2 Global Drug-Eluting Stents Revenue Forecast by Type (2021-2026)
- 6.2.3 Global Drug-Eluting Stents Price Forecast by Type (2021-2026)
- 6.3 Global Drug-Eluting Stents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
- 7.2.1 Global Drug-Eluting Stents Consumption Historic Breakdown by Application (2015-2020)
- 7.2.2 Global Drug-Eluting Stents Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
- 8.1 Boston Scientific
- 8.1.1 Boston Scientific Corporation Information
- 8.1.2 Boston Scientific Overview
- 8.1.3 Boston Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.1.4 Boston Scientific Product Description
- 8.1.5 Boston Scientific Related Developments
- 8.2 Medtronic, Inc.
- 8.2.1 Medtronic, Inc. Corporation Information
- 8.2.2 Medtronic, Inc. Overview
- 8.2.3 Medtronic, Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.2.4 Medtronic, Inc. Product Description
- 8.2.5 Medtronic, Inc. Related Developments
- 8.3 Abbott
- 8.3.1 Abbott Corporation Information
- 8.3.2 Abbott Overview
- 8.3.3 Abbott Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.3.4 Abbott Product Description
- 8.3.5 Abbott Related Developments
- 8.4 Lepu Medical
- 8.4.1 Lepu Medical Corporation Information
- 8.4.2 Lepu Medical Overview
- 8.4.3 Lepu Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.4.4 Lepu Medical Product Description
- 8.4.5 Lepu Medical Related Developments
- 8.5 MicroPort Scientific Corporation
- 8.5.1 MicroPort Scientific Corporation Corporation Information
- 8.5.2 MicroPort Scientific Corporation Overview
- 8.5.3 MicroPort Scientific Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.5.4 MicroPort Scientific Corporation Product Description
- 8.5.5 MicroPort Scientific Corporation Related Developments
- 8.6 Cook Medical
- 8.6.1 Cook Medical Corporation Information
- 8.6.2 Cook Medical Overview
- 8.6.3 Cook Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.6.4 Cook Medical Product Description
- 8.6.5 Cook Medical Related Developments
- 8.7 Terumo
- 8.7.1 Terumo Corporation Information
- 8.7.2 Terumo Overview
- 8.7.3 Terumo Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.7.4 Terumo Product Description
- 8.7.5 Terumo Related Developments
- 8.8 Biosensors International
- 8.8.1 Biosensors International Corporation Information
- 8.8.2 Biosensors International Overview
- 8.8.3 Biosensors International Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.8.4 Biosensors International Product Description
- 8.8.5 Biosensors International Related Developments
- 8.9 Balton
- 8.9.1 Balton Corporation Information
- 8.9.2 Balton Overview
- 8.9.3 Balton Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.9.4 Balton Product Description
- 8.9.5 Balton Related Developments
- 8.10 AlviMedica Medical Technologies
- 8.10.1 AlviMedica Medical Technologies Corporation Information
- 8.10.2 AlviMedica Medical Technologies Overview
- 8.10.3 AlviMedica Medical Technologies Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.10.4 AlviMedica Medical Technologies Product Description
- 8.10.5 AlviMedica Medical Technologies Related Developments
- 8.11 Biotronik
- 8.11.1 Biotronik Corporation Information
- 8.11.2 Biotronik Overview
- 8.11.3 Biotronik Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.11.4 Biotronik Product Description
- 8.11.5 Biotronik Related Developments
- 8.12 Shandong JW Medical
- 8.12.1 Shandong JW Medical Corporation Information
- 8.12.2 Shandong JW Medical Overview
- 8.12.3 Shandong JW Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.12.4 Shandong JW Medical Product Description
- 8.12.5 Shandong JW Medical Related Developments
- 8.13 Sino Medical
- 8.13.1 Sino Medical Corporation Information
- 8.13.2 Sino Medical Overview
- 8.13.3 Sino Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.13.4 Sino Medical Product Description
- 8.13.5 Sino Medical Related Developments
- 8.14 Beijing AMSINO
- 8.14.1 Beijing AMSINO Corporation Information
- 8.14.2 Beijing AMSINO Overview
- 8.14.3 Beijing AMSINO Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.14.4 Beijing AMSINO Product Description
- 8.14.5 Beijing AMSINO Related Developments
- 8.15 Liaoning Biomedical Materials R&D Center Co.(LBC)
- 8.15.1 Liaoning Biomedical Materials R&D Center Co.(LBC) Corporation Information
- 8.15.2 Liaoning Biomedical Materials R&D Center Co.(LBC) Overview
- 8.15.3 Liaoning Biomedical Materials R&D Center Co.(LBC) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.15.4 Liaoning Biomedical Materials R&D Center Co.(LBC) Product Description
- 8.15.5 Liaoning Biomedical Materials R&D Center Co.(LBC) Related Developments
9 Drug-Eluting Stents Production Forecast by Regions
- 9.1 Global Top Drug-Eluting Stents Regions Forecast by Revenue (2021-2026)
- 9.2 Global Top Drug-Eluting Stents Regions Forecast by Production (2021-2026)
- 9.3 Key Drug-Eluting Stents Production Regions Forecast
- 9.3.1 North America
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
10 Drug-Eluting Stents Consumption Forecast by Region
- 10.1 Global Drug-Eluting Stents Consumption Forecast by Region (2021-2026)
- 10.2 North America Drug-Eluting Stents Consumption Forecast by Region (2021-2026)
- 10.3 Europe Drug-Eluting Stents Consumption Forecast by Region (2021-2026)
- 10.4 Asia Pacific Drug-Eluting Stents Consumption Forecast by Region (2021-2026)
- 10.5 Latin America Drug-Eluting Stents Consumption Forecast by Region (2021-2026)
- 10.6 Middle East and Africa Drug-Eluting Stents Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Drug-Eluting Stents Sales Channels
- 11.2.2 Drug-Eluting Stents Distributors
- 11.3 Drug-Eluting Stents Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
- 12.1 Drug-Eluting Stents Industry
- 12.2 Market Trends
- 12.3 Market Opportunities and Drivers
- 12.4 Market Challenges
- 12.5 Drug-Eluting Stents Market Risks/Restraints
- 12.6 Porter's Five Forces Analysis
13 Key Finding in The Global Drug-Eluting Stents Study
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Drug-Eluting Stents . Industry analysis & Market Report on Drug-Eluting Stents is a syndicated market report, published as Global Drug-Eluting Stents Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Drug-Eluting Stents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
